A Study of Idasanutlin With Cytarabine Versus Cytarabine Plus Placebo in Participants With Relapsed or Refractory Acute Myeloid Leukemia (AML)
-
Cancer -
Leukemia
For the latest version of this information please go to www.forpatients.roche.com